FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely, experimental biology, and can be used to treat amyloid cardiopathy. Method of treatment of amyloid cardiopathy in rats is that in the background of the experimental model of systemic cardiopathic amyloidosis, 3 % solution of acisol is introduced to rats at the rate of 0.03 ml/g of body weight.
EFFECT: method provides reduction of the morphological signs of cardiopathy formed in the experiment and its functional manifestations, expanding the possibilities of treating such a pathology.
1 cl, 3 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SIMULATING EXPERIMENTAL AMYLOID CARDIOPATHY IN RATS | 2013 |
|
RU2556571C1 |
| METHOD FOR PREVENTION OF EXPERIMENTAL CARDIOPATHY | 2013 |
|
RU2531139C1 |
| METHOD OF MODELLING EXPERIMENTAL CARDIOPATHY | 2012 |
|
RU2530758C2 |
| METHOD OF MODELLING EXPERIMENTAL AMYLOIDOSIS IN RATS | 2009 |
|
RU2410761C1 |
| METHOD FOR SIMULATING GENERALISED AMYLOIDOSIS IN ANIMALS | 2013 |
|
RU2536556C2 |
| METHOD OF PREVENTING SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATIC FORM IN EXPERIMENTAL ANIMALS | 2009 |
|
RU2410764C1 |
| METHOD OF SIMULATING AMYLOIDOSIS IN ANIMALS | 2008 |
|
RU2373581C1 |
| METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC CONDITION IN EXPERIMENTAL ANIMALS | 2008 |
|
RU2386415C1 |
| METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC FORM IN EXPERIMENTAL ANIMALS | 2011 |
|
RU2473133C2 |
| METHOD FOR SIMULATING EXPERIMENTAL AMYLOID THYREOPATHY IN RATS | 2020 |
|
RU2732008C1 |
